PPT_Chapter_48_updated - Drugs Affecting Blood Coagulation Chapter 48 Copyright 2013 Wolters Kluwer Health | Lippincott Williams Wilkins Blood Vessel

PPT_Chapter_48_updated - Drugs Affecting Blood Coagulation...

This preview shows page 1 - 13 out of 56 pages.

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Affecting Blood Coagulation Chapter 48
Image of page 1
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Blood Vessel Injury Local vasoconstriction seals off small injury Platelet aggregation forms a platelet plug Hageman factor is activated (factor XII) Intrinsic pathway converts prothrombin to thrombin to seal system Extrinsic pathway clots the blood that has leaked out of the vascular system
Image of page 2
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Process of Blood Coagulation
Image of page 3
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Damaged Vessel Endothelium is a Stimulus to Platelets, Causing Platelet Adhesion
Image of page 4
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Types of Blood Disorders Thromboembolic Disorder Conditions that predispose a person to the formation of clots and emboli Hemorrhagic Disorder Disorder in which excess bleeding occurs
Image of page 5
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Question How do antiplatelet medications work? A. Interfere with the clotting cascade B. Alter the formation of the platelet plug C. Stimulates the plasmin system D. Initiates the clotting cascade
Image of page 6
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer B. Alter the formation of the platelet plug Rationale: Antiplatelets alter the formation of the platelet plug.
Image of page 7
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Actions of Anticoagulants Anticoagulants Interfere with the clotting cascade and thrombin formation Antiplatelets Alter the formation of the platelet plug Thrombolytic Drugs Break down the thrombus that has been formed by stimulating the plasmin system
Image of page 8
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Antiplatelet Abciximab (ReoPro) Anagrelide (Agrylin) Aspirin Cilostazol (Pletal) Clopidogrel (Plavix) Dipyridamole (Persantine) Eptifibatide (Integrilin) Ticlopidine (Ticlid) Ticagrelor (Brilinta) Tirofiban (Aggrastat)
Image of page 9
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Antiplatelet (cont.) Actions Inhibit platelet adhesion and aggregation by blocking receptors sites on the platelet membrane Anagrelide Blocks the production of platelets in the bone marrow Indications Reduce risk of recurrent TIAs or strokes; reduce death or nonfatal MI; MI prophylaxis; anti-inflammatory, analgesic, and antipyretic effects Pharmacokinetics Well absorbed and bound to plasma proteins Metabolized in the liver and excreted in the urine
Image of page 10
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Antiplatelet (cont.) Contraindications Allergy, pregnancy, and lactation Caution Bleeding disorder, recent surgery, closed-head injury Adverse Effects Bleeding Headache, dizziness, and weakness GI distress Drug-to-Drug Interactions Another drug that affects blood clotting
Image of page 11
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Prototype Antiplatelets
Image of page 12
Image of page 13

You've reached the end of your free preview.

Want to read all 56 pages?

  • Summer '16
  • Wolters Kluwer Health, Lippincott Williams & Wilkins

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture